1060 related articles for article (PubMed ID: 19016708)
1. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.
Johansen C; Usher PA; Kjellerup RB; Lundsgaard D; Iversen L; Kragballe K
Br J Dermatol; 2009 Feb; 160(2):319-24. PubMed ID: 19016708
[TBL] [Abstract][Full Text] [Related]
2. Involvement of IL-17F via the induction of IL-6 in psoriasis.
Fujishima S; Watanabe H; Kawaguchi M; Suzuki T; Matsukura S; Homma T; Howell BG; Hizawa N; Mitsuya T; Huang SK; Iijima M
Arch Dermatol Res; 2010 Sep; 302(7):499-505. PubMed ID: 20148256
[TBL] [Abstract][Full Text] [Related]
3. Compressive force stimulates the gene expression of IL-17s and their receptors in MC3T3-E1 cells.
Zhang F; Wang CL; Koyama Y; Mitsui N; Shionome C; Sanuki R; Suzuki N; Mayahara K; Shimizu N; Maeno M
Connect Tissue Res; 2010 Oct; 51(5):359-69. PubMed ID: 20497006
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-17F affects cartilage matrix turnover by increasing the expression of collagenases and stromelysin-1 and by decreasing the expression of their inhibitors and extracellular matrix components in chondrocytes.
Tanigawa S; Aida Y; Kawato T; Honda K; Nakayama G; Motohashi M; Suzuki N; Ochiai K; Matsumura H; Maeno M
Cytokine; 2011 Nov; 56(2):376-86. PubMed ID: 21885294
[TBL] [Abstract][Full Text] [Related]
5. IL-17F/IL-17R interaction stimulates granulopoiesis in mice.
Tan W; Huang W; Gu X; Zhong Q; Liu B; Schwarzenberger P
Exp Hematol; 2008 Nov; 36(11):1417-27. PubMed ID: 18723265
[TBL] [Abstract][Full Text] [Related]
6. Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy.
Johansen C; Vinter H; Soegaard-Madsen L; Olsen LR; Steiniche T; Iversen L; Kragballe K
Br J Dermatol; 2010 Dec; 163(6):1194-204. PubMed ID: 20846304
[TBL] [Abstract][Full Text] [Related]
7. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.
Leppkes M; Becker C; Ivanov II; Hirth S; Wirtz S; Neufert C; Pouly S; Murphy AJ; Valenzuela DM; Yancopoulos GD; Becher B; Littman DR; Neurath MF
Gastroenterology; 2009 Jan; 136(1):257-67. PubMed ID: 18992745
[TBL] [Abstract][Full Text] [Related]
8. Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.
Johansen C; Kragballe K; Rasmussen M; Dam TN; Iversen L
Br J Dermatol; 2004 Sep; 151(3):600-7. PubMed ID: 15377346
[TBL] [Abstract][Full Text] [Related]
9. Demonstration and functional analysis of IL-10 receptors in human epidermal cells: decreased expression in psoriatic skin, down-modulation by IL-8, and up-regulation by an antipsoriatic glucocorticosteroid in normal cultured keratinocytes.
Michel G; Mirmohammadsadegh A; Olasz E; Jarzebska-Deussen B; Müschen A; Kemény L; Abts HF; Ruzicka T
J Immunol; 1997 Dec; 159(12):6291-7. PubMed ID: 9550434
[TBL] [Abstract][Full Text] [Related]
10. Chosen IL-17 family proteins in neutrophils of patients with oral inflammation.
Garley M; Jablonska E
Adv Med Sci; 2008; 53(2):326-30. PubMed ID: 19095584
[TBL] [Abstract][Full Text] [Related]
11. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
[TBL] [Abstract][Full Text] [Related]
12. Different T cell subsets in the nodule and synovial membrane: absence of interleukin-17A in rheumatoid nodules.
Stamp LK; Easson A; Lehnigk U; Highton J; Hessian PA
Arthritis Rheum; 2008 Jun; 58(6):1601-8. PubMed ID: 18512780
[TBL] [Abstract][Full Text] [Related]
13. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro.
Schulz BS; Michel G; Wagner S; Süss R; Beetz A; Peter RU; Kemény L; Ruzicka T
J Immunol; 1993 Oct; 151(8):4399-406. PubMed ID: 7691948
[TBL] [Abstract][Full Text] [Related]
15. [Intralesional and anatomopathologic features of psoriatic erythroderma].
Samoud El Kissi S; Cherif Ben Hmida F; Ben Osman Dahri A; Boubacker MS; Hechmi-Louzir M
Tunis Med; 2007 Jul; 85(7):573-5. PubMed ID: 18064989
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes.
Zrioual S; Ecochard R; Tournadre A; Lenief V; Cazalis MA; Miossec P
J Immunol; 2009 Mar; 182(5):3112-20. PubMed ID: 19234208
[TBL] [Abstract][Full Text] [Related]
17. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques.
de Boer OJ; van der Meer JJ; Teeling P; van der Loos CM; Idu MM; van Maldegem F; Aten J; van der Wal AC
J Pathol; 2010 Mar; 220(4):499-508. PubMed ID: 20020510
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin.
Yu H; Mrowietz U; Seifert O
Acta Derm Venereol; 2009; 89(4):351-6. PubMed ID: 19688145
[TBL] [Abstract][Full Text] [Related]
20. Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions.
Chen SC; de Groot M; Kinsley D; Laverty M; McClanahan T; Arreaza M; Gustafson EL; Teunissen MB; de Rie MA; Fine JS; Kraan M
Arch Dermatol Res; 2010 Mar; 302(2):113-23. PubMed ID: 19517126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
